● Live Tracking 375+ pre-IPO companies with institutional-grade data — updated daily. 140 in active pipeline.

Tempus AI IPO Status 2026

AI-powered precision medicine platform analyzing clinical and molecular data.

IndustryBiotechnology
StageRecent IPO
IPO StatusPublic
Valuation$8B
Total Funding$1.3B
HeadquartersChicago, IL
CEOEric Lefkofsky
How to Invest in Tempus AI
Public
📈 Buy Tempus AI Now

Tempus AI is now publicly traded. All investors welcome — no accreditation required.

🐦
Robinhood
Buy → 📱
Webull
Buy → 🌐
Public.com
Buy → 💳
SoFi
Buy →
📡 IPO Intelligence
$49/mo — Unlimited Reports + Real-Time Updates
⚡Unlimited company analysis reports — all 375+ companies
✓Real-time IPO alerts — know the moment S-1s are filed
✓Verified data updated daily — not chatbot hallucinations
💡 Tracking multiple companies? Full access pays for itself after 3 reports.
$49
per month
Subscribe Now →
Cancel anytime · Secure via Stripe
Institutional Research
$19 — Get the Complete Tempus AI Analysis Brief
✓Executive summary & IPO readiness breakdown
✓Competitive positioning & funding trajectory
✓Bull / bear thesis with pricing projections
✓S-1 timeline estimate & risk assessment
$19
One-time
Secure checkout · Stripe · 24h delivery

Frequently Asked Questions

What is Tempus AI's current valuation? +

Tempus AI is valued at $8B as of June 2024.

Has Tempus AI filed for an IPO? +

Tempus AI has filed an S-1 registration statement with the SEC on May 20, 2024, indicating an active IPO process.

How much total funding has Tempus AI raised? +

Tempus AI has raised $1.3B in total venture capital funding.

What sector is Tempus AI in? +

Tempus AI is a Biotechnology company. AI-powered precision medicine platform analyzing clinical and molecular data.

What is Tempus AI's IPO readiness score? +

Tempus AI scores 72/100 on TechStackIPO's IPO readiness index, which evaluates funding stage, valuation trajectory, S-1 filing status, and market timing signals.